Skip to main content
. 2022 Apr 26;43(12):1859–1866. doi: 10.1017/ice.2022.23

Table 3.

Outcomes of EVD Infections

Age and Sex EVD Indication Drainage Duration, Days Infection Onset, Day Organism(s) Antibiotic(s) Antibiotic Duration, Days 30-Day Outcome, mRS
71M Shunt failure 2 1 CoNS Vancomycin 10 6 a
66M IVH 6 5 MSSA Nafcillin 42 4
34M IVH 11 9 CoNS Vancomycin 28 3
59M SAH 10 9 CoNS Vancomycin 14 4
66M SAH 2 2 C. acnes
CoNS
Meropenem 10 4
58M IVH 6 5 CoNS Vancomycin 14 4
65F TBI, SDH 3 3 C. koseri Gentamicin IT
Meropenem IV
42 6 a
25M IVH 12 11 P. agglomerans
M. luteum
Cefepime, vancomycin 14 4
45M SAH 18 16 CoNS Vancomycin 14 3

Note. EVD, external ventricular drain; IVH, intraventricular hemorrhage; SAH, subarachnoid hemorrhage; TBI, traumatic brain injury; SDH, subdural hematoma; CoNS, coagulase-negative staphylococci; MSSA, methicillin-sensitive Staphylococcus aureus; C. acnes, Cutibacterium acnes; C. koseri, Citrobacter koseri; P. agglomerans, Pantoea agglomerans; M. luteus, Micrococcus luteum; IT, intrathecal; IV, intravenous; mRS, modified Rankin Scale score (3=moderate disability, 4=severe disability, 6=death).

a

Pateint died.